Acne in women

British Journal of Dermatology

Volumn 172, Issue S1, 2015, Pages 20-26

  Ramos E Silva, M ^a   Ramos E Silva, S ^a   Carneiro, S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ANTIANDROGEN; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; GLYCOLIC ACID; RETINOID; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT;

ACNE; BODY IMAGE; CLINICAL FEATURE; FEMALE; HUMAN; MICRODERMABRASION; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; REVIEW; SCAR; SELF ESTEEM; SKIN ABRASION; SOCIAL ENVIRONMENT; ACNE VULGARIS; ADULT; CICATRIX; PROCEDURES;

ACNE VULGARIS; ADULT; ANDROGEN ANTAGONISTS; ANTI-BACTERIAL AGENTS; CICATRIX; DERMABRASION; DERMATOLOGIC AGENTS; FEMALE; HUMANS; RETINOIDS;

EID: 84931834135     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13638     Document Type: Review

References (77)

1. Bergfeld WF,. A lifetime of healthy skin: implications for women. Int J Fertil Womens Med 1999; 44: 83-95.
2. Goulden V, Stables GI, Cunliffe WJ,. Prevalence of facial acne in adults. J Am Acad Dermatol 1999; 41: 577-80.
3. Duarte de Sá CM,. Acne na Mulher Adulta. Rio de Janeiro: Publicações Científicas, 2000.
4. Shuster S, Fisher GH, Harris E, Binnell D,. The effect of skin disease on self-image [proceedings]. Br J Dermatol 1978; 99 (Suppl. 16): 18-19.
5. Cunliffe WJ,. Acne and unemployment. Br J Dermatol 1986; 115: 386.
6. Walton S, Wyatt EH, Cunliffe WJ,. Genetic control of sebum excretion and acne-a twin study. Br J Dermatol 1988; 118: 393-6.
7. Walton S, Cunliffe WJ, Keczkes K, et al,. Clinical, ultrasound, and hormonal markers of androgenicity in acne vulgaris. Br J Dermatol 1995; 133: 249-53.
8. Lucky AW, McGuire J, Rosenfield RL, et al,. Plasma androgens in women with acne vulgaris. J Invest Dermatol 1983; 81: 70-4.
9. Lawrence D, Shaw M, Katz M,. Elevated free testosterone concentration in men and women with acne vulgaris. Clin Exp Dermatol 1985; 11: 263-73.
10. Schiavone F, Rietschel RL, Sgoutas D, Harris R,. Elevated free testosterone levels in women with acne. Arch Dermatol 1983; 119: 799-802.
11. Sutherland H, Stewart I,. A critical analysis of the premenstrual syndrome. Lancet 1965; 1: 1180-3.
12. Holzmann R, Shakery K,. Postadolescent acne in females. Skin Pharmacol Physiol 2014; 27: 3-8.
13. Zeichner JA,. Evaluating and treating the adult female patient with acne. J Drugs Dermatol 2013; 12: 1416-27.
14. Goulden V, Clark SM, Cunliffe WJ,. Post-adolescent acne: review of clinical features. Br J Dermatol 1997; 136: 66-70.
15. Stern RS,. The prevalence of acne on the basis of physical examination. J Am Acad Dermatol 1992; 26: 931-5.
16. Khanna N, Gupta SD,. Acneiform eruptions after facial beauty treatment. Int J Dermatol 1999; 38: 196-9.
17. Choi CW, Lee DH, Kim HS, et al,. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25: 454-61.
18. McGeown CH, Goulden V, Holland DB, et al,. Sebum excretion rate in post-adolescent acne compared to controls and adolescent acne. J Invest Dermatol 1997; 108: 386.
19. Youn SW, Park ES, Lee DH, et al,. Does facial sebum excretion really affect the development of acne? Br J Dermatol 2005; 153: 919-24.
20. Balin AD, Kligman AM,. Aging and the Skin. New York: Raven Press, 1989.
21. Plewig G, Kligman AM,. Perimenopausal and postmenopausal acne. In: Acne and Rosacea (, Plewig G, Kligman AM, eds), 3rd edn. Berlin: Springer-Verlag, 2000; 369.
22. Picardi A, Abeni D, Melchi CF, et al,. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-91.
23. Zaraa I, Belghith I, Ben Alaya N, et al,. Severity of acne and its impact on quality of life. Skinmed 2013; 11: 148-53.
24. Koblenzer CS,. Psychodermatology of women. Clin Dermatol 1997; 15: 127-41.
25. Cotterill JA, Cunliffe WJ,. Suicide in dermatological patients. Br J Dermatol 1997; 137: 246-50.
26. Gupta MA, Gupta AK, Schork NJ,. Psychological factors affecting self-excoriative behavior in women with mild-to-moderate facial acne vulgaris. Psychosomatics 1996; 37: 127-30.
27. Kellett SC, Gawkrodger DJ,. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273-82.
28. Thiboutot DM, Lookingbill DP,. Acne: acute or chronic disease? J Am Acad Dermatol 1995; 32: S2-5.
29. Brenner S, Politi Y,. Dermatologic diseases and problems of women throughout the life cycle. Int J Dermatol 1995; 34: 369-79.
30. Usatine RP, Quan MA,. Pearls in the management of acne: an advanced approach. Prim Care 2000; 27: 289-308.
31. Tanghetti EA, Kawata AK, Daniels SR, et al,. Understanding the burden of adult female acne. J Clin Aesthet Dermatol 2014; 7: 22-30.
32. Sperling L, Heimer WL 2nd,. Androgen biology as basis for diagnosis and treatment of androgenetic disorders in women. J Am Acad Dermatol 1993; 28: 669-83.
33. Timpatanapong P, Rojanasakul A,. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol 1997; 24: 223-9.
34. Slayden SM, Moran C, Sams WM Jr, et al,. Hyperandrogenemia in patients presenting with acne. Fertil Steril 2001; 75: 889-92.
35. Olsen C, Green A, Nagle C, et al,. Epithelial ovarian cancer: testing the androgens hypothesis. Endocr Relat Cancer 2008; 15: 1061-8.
36. Brazzelli V, Larizza D, Muzio F, et al,. Low frequency of acne vulgaris in adolescent girls and women with Turner's syndrome: a clinical, genetic and hormonal study of 65 patients. Br J Dermatol 2008; 159: 1209-11.
37. Gollnick HP, Finlay AY, Shear N,. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9: 279-84.
38. Shaw JC,. Antiandrogen and hormonal treatment of acne. Dermatol Clin 1996; 14: 803-11.
39. Castro AC,. Uso de cosmético. In: Acne Manejo Racional (, Piquero-Martin J, ed). Caracas: Editora Corpográfica, 2000; 207-15.
40. Vozmediano JMF, Rita JCA, Cabrera NF,. Ácido glicõlico y otros alfa-hidroxiácidos. In: Acne Manejo Racional (, Piquero-Martin J, ed). Caracas: Editora Corpográfica, 2000; 295-300.
41. Rondõn-Lugo A,. Antibiõticos tõpicos. In: Acne: um Enfoque Global (, Kaminski A, Flõrez-White M, eds). Buenos Aires: Alfaomega, 2012; 163-9.
42. Flõres-White M,. Perõxido de benzoílo y ácido azelaico. In: Acne: um Enfoque Global (, Kaminski A, Flõrez-White M, eds). Buenos Aires: Alfaomega, 2012; 153-62.
43. Ramos-e-Silva M, Carneiro SC,. Acne vulgaris: review and guidelines. Dermatol Nurs 2009; 21: 63-8.
44. Bagatin E,. Adult female acne. Azelaic acid in the treatment of acne in adult females. Introduction. Skin Pharmacol Physiol 2014; 27: 1-2.
45. Stern RS,. Medication and medical service utilization for acne-1995-1998. J Am Acad Dermatol 2000; 43: 1042-8.
46. Auffret N,. Acne today. What's new? Presse Med 2000; 29: 1091-7.
47. Ghaffarpour G, Mazloomi S, Soltani-Arabshahi R, Seyed KS,. Oral isotretinoin for acne, adjusting treatment according to patient's response. J Drugs Dermatol 2006; 5: 878-82.
48. Dréno B, Bettoli V, Ochsendorf F, et al,. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 16: 565-71.
49. Cordero A,. Retinõides tõpicos. In: Acne Manejo Racional (, Piquero-Martin J, ed). Caracas: Editora Corpográfica, 2000; 263-5.
50. Meigel WN,. How safe is oral isotretinoin? Dermatology 1997; 195: 22-8; discussion 38-4.
51. Leyden JJ,. Oral isotretinoin. How can we treat difficult acne patients? Dermatology 1997; 195: 29-33; discussion 38-40.
52. Cunliffe WJ,. Management of adult acne and acne variants. J Cutan Med Surg 1998; 3: 7-13.
53. Cunliffe WJ,. Acne: when, where and how to treat. Practitioner 2000; 244: 865-71.
54. Bershad SV,. The modern age of acne therapy: a review of current treatment options. Mt Sinai J Med 2001; 68: 279-86.
55. Lehucher-Ceyrac D, Chaspoux C, Weber MJ, et al,. [Acne, hyperandrogenism and oral isotretinoin resistance-23 cases. Therapeutic implications]. Ann Dermatol Venereol 1997; 124: 692-5 (in French).
56. Lubbos HG, Hasinski S, Rose LI, Pollock J,. Adverse effects of spironolactone therapy in women with acne. Arch Dermatol 1998; 134: 1162-3.
57. Lucky AW, Henderson TA, Olson WH, et al,. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol 1997; 37: 746-54.
58. Faure M, Drapier-Faure E,. [Hormonal assessment in a woman with acne and alopecia]. Rev Fr Gynecol Obstet 1992; 87: 331-4. (in French).
59. Koulianos GT,. Treatment of acne with oral contraceptives: criteria for pill selection. Cutis 2000; 66: 281-6.
60. Burkman RT,. Oral contraceptives: current status. Clin Obstet Gynecol 2001; 44: 62-72.
61. Redmond GP, Olson WH, Lippman JS, et al,. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. Obstet Gynecol 1997; 89: 615-22.
62. Stern RS,. Acne therapy. Medication use and sources of care in office-based practice. Arch Dermatol 1996; 132: 776-80.
63. Gollnick H, Albring M, Brill K,. The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type. Ann Endocrinol (Paris) 1999; 60: 157-66.
64. Cirigliano MC,. Hormonas. In: Acne: um Enfoque Global (, Kaminski A, Flõrez-White M, eds). Buenos Aires: Alfaomega, 2012; 218-23
65. Gruber DM, Sator MO, Joura EA, et al,. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial. Arch Dermatol 1998; 134: 459-63.
66. Shaw JC,. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 2000; 43: 498-502.
67. Lübbert C, Wiese M, Haupt R, Ruf BR,. Toxic hepatitis and liver failure under therapy with flutamide. Der Internist 2004; 45: 333-40.
68. Fernandez-Obregon AC,. Azithromycin for the treatment of acne. Int J Dermatol 2000; 39: 45-50.
69. Kempiak SJ, Uebelhoer NU,. Superficial chemical peels and microdermabrasion for acne vulgaris. Semin Cutan Med Surg 2008; 27: 212-20.
70. Lloyd JR,. The use of microdermabrasion for acne: a pilot study. Dermatol Surg 2001; 27: 329-31.
71. Tan MH, Spencer JM, Pires LM, et al,. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. Dermatol Surg 2001; 27: 943-9.
72. Karimipour DJ, Karimipour G, Orringer JS,. Microdermabrasion: an evidence-based review. Plast Reconstr Surg 2010; 125: 372-7.
73. Jacob CI, Dover JS, Kaminer MS,. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001; 45: 109-17.
74. Sánchez Viera M,. Management of acne scars: fulfilling our duty of care for patients. Br J Dermatol 2015; 172 (Suppl. 1): 47-51.
75. Cunliffe W, Gollnick H,. Clinical features of acne. In: Acne. Diagnosis and Management. London: Martin Dunitz, 2000; 49-67.
76. Guimarães CMDS,. Acne da mulher adulta. In: Fundamentos de Dermatologia. (, M Ramos-e-Silva, MCR Castro, eds), Rio de Janeiro: Atheneu, 2009, 807-17.
77. Plewig G, Kligman AM,. Postadolescent acne in women. In: Acne and Rosacea (, Plewig G, Kligman AM, eds), 3rd edn. Berlin: Springer-Verlag, 2000; 365.